BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26673998)

  • 21. Evaluation for Synergistic Effects by Combinations of Photodynamic Therapy (PDT) with Temoporfin (mTHPC) and Pt(II) Complexes Carboplatin, Cisplatin or Oxaliplatin in a Set of Five Human Cancer Cell Lines.
    Lange C; Bednarski PJ
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of the photodynamic action of hypericin.
    Saw CL; Heng PW; Olivo M
    J Environ Pathol Toxicol Oncol; 2008; 27(1):23-33. PubMed ID: 18551893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decitabine exerted synergistic effects with oxaliplatin in colorectal cancer cells with intrinsic resistance to decitabine.
    Hosokawa M; Tanaka S; Ueda K; Iwakawa S; Ogawara KI
    Biochem Biophys Res Commun; 2019 Jan; 509(1):249-254. PubMed ID: 30581001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.
    Jendzelovský R; Mikes J; Koval' J; Soucek K; Procházková J; Kello M; Sacková V; Hofmanová J; Kozubík A; Fedorocko P
    Photochem Photobiol Sci; 2009 Dec; 8(12):1716-23. PubMed ID: 20024169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericin.
    Sanovic R; Krammer B; Grumboeck S; Verwanger T
    Int J Oncol; 2009 Oct; 35(4):921-39. PubMed ID: 19724930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells].
    Zhang Y; Sun XW; Xu JH; Lu H; Fan ZZ; Sun J; Zhang XX
    Zhong Xi Yi Jie He Xue Bao; 2012 Aug; 10(8):901-10. PubMed ID: 22883407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin.
    Mohn C; Häcker HG; Hilger RA; Gütschow M; Jaehde U
    Pharmazie; 2013 Jul; 68(7):622-7. PubMed ID: 23923647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypericin-loaded oil-in-water nanoemulsion synthesized by ultrasonication process enhances photodynamic therapy efficiency.
    Ma HL; Varanda LC; Perussi JR; Carrilho E
    J Photochem Photobiol B; 2021 Oct; 223():112303. PubMed ID: 34509718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
    Dong Y; Wang Z; Xie GF; Li C; Zuo WW; Meng G; Xu CP; Li JJ
    Mol Cancer; 2017 Mar; 16(1):71. PubMed ID: 28356150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypericin induced death receptor-mediated apoptosis in photoactivated tumor cells.
    Ali SM; Chee SK; Yuen GY; Olivo M
    Int J Mol Med; 2002 Jun; 9(6):601-16. PubMed ID: 12011977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane.
    Majerník M; Jendželovský R; Babinčák M; Košuth J; Ševc J; Tonelli Gombalová Z; Jendželovská Z; Buríková M; Fedoročko P
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin.
    Kleban J; Szilárdiová B; Mikes J; Horváth V; Sacková V; Brezáni P; Hofmanová J; Kozubík A; Fedorocko P
    J Photochem Photobiol B; 2006 Aug; 84(2):79-88. PubMed ID: 16545574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin.
    Kleban J; Mikes J; Horváth V; Sacková V; Hofmanová J; Kozubík A; Fedorocko P
    J Photochem Photobiol B; 2008 Nov; 93(2):108-18. PubMed ID: 18771933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of resistance to oxaliplatin by vorinostat in human colorectal cancer cells through inhibition of Nrf2 nuclear translocation.
    Tanaka S; Hosokawa M; Tatsumi A; Asaumi S; Imai R; Ogawara KI
    Biochem Biophys Res Commun; 2022 Jun; 607():9-14. PubMed ID: 35358872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines.
    Noordhuis P; Laan AC; van de Born K; Honeywell RJ; Peters GJ
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoprotective role of nitric oxide in HepG2 cell apoptosis induced by hypocrellin B photodynamic treatment.
    Ji YY; Ma YJ; Wang JW
    J Photochem Photobiol B; 2016 Oct; 163():366-73. PubMed ID: 27619738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower sensitivity of FHC fetal colon epithelial cells to photodynamic therapy compared to HT-29 colon adenocarcinoma cells despite higher intracellular accumulation of hypericin.
    Mikeš J; Hýžďalová M; Kočí L; Jendželovský R; Kovaľ J; Vaculová A; Hofmanová J; Kozubík A; Fedoročko P
    Photochem Photobiol Sci; 2011 Apr; 10(4):626-32. PubMed ID: 21298151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.
    Chen B; Roskams T; Xu Y; Agostinis P; de Witte PA
    Int J Cancer; 2002 Mar; 98(2):284-90. PubMed ID: 11857421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells.
    Liu MN; Liu AY; Du YJ; Pei FH; Wang XH; Chen J; Liu D; Liu BR
    Mol Med Rep; 2015 Jul; 12(1):1189-96. PubMed ID: 25777765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.